- GlobeNewswire•8 days ago
PALATINE, Ill., March 17, 2017-- Acura Pharmaceuticals, Inc. and MainPointe Pharmaceuticals, LLC today announced that they have entered into a License Agreement to have MainPointe exclusively market NEXAFED ...
- GlobeNewswire•last month
PALATINE, Ill., Feb. 15, 2017-- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that shares of its common stock will begin to trade on ...
- Zacks•2 months ago
Options traders are pricing in a big move for Acura (ACUR) shares as it has huge implied volatility.
ACUR : Summary for ACURA PHARMACEUTIC COM USD0.01 - Yahoo Finance
Acura Pharmaceuticals, Inc. (ACUR)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.55 - 0.59|
|52 Week Range||0.46 - 3.52|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|